Curtis Gale Oltmans's Net Worth

$849 Thousand

Estimate Recalculated Nov 8, 2024 04:33PM EST

Who is Curtis Gale Oltmans?

Curtis Gale Oltmans does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., AVENUE THERAPEUTICS, INC., and ARRAY BIOPHARMA INC.

SEC CIK

Curtis Gale Oltmans's CIK is 0001714982

Past Insider Trading and Trends

2019 was Curtis Gale Oltmans's most active year for acquiring shares with 5 total transactions. Curtis Gale Oltmans's most active month to acquire stocks was the month of November. 2019 was Curtis Gale Oltmans's most active year for disposing of shares, totalling 9 transactions. Curtis Gale Oltmans's most active month to dispose stocks was the month of December. 2019 saw Curtis Gale Oltmans paying a total of $769,734.00 for 86,100 shares, this is the most they've acquired in one year. In 2019 Curtis Gale Oltmans cashed out on 161,100 shares for a total of $1,431,180.66, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54

Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Apr 26
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Aug 9
Form 4
—
0
—
—
0
Jan 19
Form 4
∞
1.09K
$9.01
$9,802.88
1.09K
Jun 28
Form 4
—
0
—
—
0
Dec 3
Form 3
—
0
—
—
0
No matching records found

AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $2.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 30
Form 4
∞
49.02K
—
—
49.02K
Dec 17
Form 3
—
0
—
—
0
No matching records found

ARRAY BIOPHARMA INC No price found

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+283.09%
11.1K
$14.47
-$343,166.00
15.02K
Scheduled
Jan 29 - Feb 5
Form 4
—
0
$13.47
-$127,104.14
3.92K
Scheduled
Jan 25 - Jan 29
Form 4
—
0
$13.47
-$11,334.06
3.92K
Scheduled
Jan 18
Form 4
—
0
$13.50
-$179,842.46
3.92K
Scheduled
Jan 15
Form 4
∞
3.92K
$15.97
-$49,171.63
3.92K
Dec 14 - Dec 16
Form 4
—
0
—
—
0
Aug 15
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Dec 16
Form 3
—
0
—
—
0
No matching records found